retatrutide study results How Does Work? Doctor Explains Why It's So Effective 🚨The first phase 3 retatrutide

The bone health implications are particularly concerning for women over 40, post-menopausal women, and anyone with a family history of osteoporosis

Rapid weight loss can be associated with reductions in bone mineral density, which is of particular relevance to perimenopausal and postmenopausal women who are already at increased risk of osteoporosis

Ozempic is FDA approved to treat type 2 diabetes, and Medicare Part D has always covered it for that purpose, subject to your plans drug list and rules

In March 2026, Retatrutide met its primary endpoints in a Phase 3 diabetes trial (TRANSCEND-T2D-1), with results suggesting superior HbA1c reductions versus comparators